Loading data
CXTNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.66 bn USD | 1.49 bn USD | 1.39 bn USD | 1.34 bn USD | 1.35 bn USD |
| Cost of revenue | 952.9 m USD | 821.7 m USD | 737.2 m USD | 713.7 m USD | 746.2 m USD |
| Research and development expense | 46 m USD | 39.5 m USD | 42.8 m USD | 33.9 m USD | 33.2 m USD |
| Selling, general and administrative expense | 440.3 m USD | 386.2 m USD | 366.8 m USD | 318.7 m USD | 323.4 m USD |
| Operating profit | 246.7 m USD | 268.8 m USD | 286.8 m USD | 301.3 m USD | 279.2 m USD |
| Interest expense | — | — | — | 52.2 m USD | 46.9 m USD |
| Profit before tax | 181 m USD | 226.4 m USD | 239.8 m USD | 248.3 m USD | 226.1 m USD |
| Income tax expense | 35.9 m USD | 42.3 m USD | 51.5 m USD | 43.4 m USD | 48.1 m USD |
| Net income (reported basis) | 145.1 m USD | 184.1 m USD | 188.3 m USD | 204.9 m USD | 178 m USD |
| Basic earnings per share | 2.53 USD/share | 3.22 USD/share | 3.31 USD/share | 3.61 USD/share | 3.14 USD/share |
| Diluted earnings per share | 2.5 USD/share | 3.19 USD/share | 3.28 USD/share | 3.61 USD/share | 3.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.